International Congress of Immunology (IUIS) 2025

EXHIBITION SPONSOR

Attending the IUIS 2025 congress in Vienna offers a unique opportunity to engage with cutting-edge immunology research, network with global experts, and advance your career. The congress, hosted by the International Union of Immunological Societies (IUIS), will feature a diverse scientific program, including presentations from rising stars and opportunities for in-depth discussions.

Grab a lunch and join us on Wednesday 20th August for a workshop highlighting real-data insights gained from the NULISA platform, from two Europe-based researchers.ย 

Visit us at Booth #71

Exhibitors Workshop

Wednesday, 20 August | 12:30-13:15 CEST

Room 1.34

Attomolar-Sensitive Profiling of Inflammatory Proteins Reveals Novel Mechanisms of Immune Response

From environmental exposure to immunotherapy, the in-event Alamar Biosciences sponsored session explores how ultra-sensitive, high-plex proteomics is accelerating translational immunology and uncovering clinically relevant immune mechanisms. Joined by key researchers in immunology research, the session showcases how attomolar-level protein detection is redefining whatโ€™s possible in biomarker discovery and immune system profiling.

If your research aims to inform the clinic, this session will show how next-generation proteomics is making that leapโ€”from signal to significance.

NULISA: Fully automated ultra-sensitive fluid biomarker platform

Michael Evans
Director of Sales, EMEA
Alamar Biosciences

Molecular signatures of environmental influence in the circulation

Prof.โ€ฏCezmi Akdis, MD.ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  Director of the Swiss Institute of Allergy and Asthmaย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  ย  University of Zurich, Switzerlandย 
Research (SIAF)

Systems immunology reveals the first-week cellular and molecular mechanisms underlying successful insect-venom allergen-specific immunotherapy

Dr.โ€ฏFeng HeFeng, PhD, ADR
Senior Researcher, Translational and Clinical Immunologyย  ย  ย  ย  ย  ย  ย  ย  Luxembourgย Institute of Health, Luxembourg

Steve Williams, MD, PhD

CSO

Dr. Willams serves as the company’s Chief Scientific Officer. Heย was previously Chief Medical Officer at Standard Biotools and at SomaLogic where he pioneered the discipline for discovery and validation of predictive, diagnostic and prognostic models using machine-learning applied to large-plex proteomics. 20 such tests were used for drug characterization, safety and efficacy when incorporated in clinical drug trials at Pharma/Biotech and 17 different multivariate tests were validated and translated into regulated healthcare uses. Prior to SomaLogic, Dr. Williams was at Pfizer in the UK and the USA as a clinical triallist in Translational Medicine, and subsequently as VP, Global Clinical Technology. He sat on the National Advisory Council for the National Institute of Biomedical Imaging and Bioengineering, the Executive Committee for the FNIH Biomarkers Consortium, and worked with FDA and PhRMA on developing evidentiary standards for biomarker qualification. Dr. William’s medical training was in London, at Charing Cross and Westminster Medical School, followed by a PhD in medicine/physiology at the same institution and training in Radiology at the University of Newcastle Upon Tyne. Steve is co-inventor on 26 proteomics patents and author/coauthor on multiple foundational proteomics manuscripts.

Justin McAnear

CFO

Mr. McAnear serves as the company’s Chief Financial Officer. He brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Mr. McAnear served for over 3 years as Teslaโ€™s VP of Worldwide Finance and Operations, supporting landmark initiatives such as the Model X and Model 3 launches and Solar City acquisition.  He also held various roles at Apple and J&J earlier in his career and served as a naval officer and aviator for over 9 years.